Today on Outsourcing-Pharma.com   Pfizer reveals latest Exubera casualties Contract downturns cause Catalent cutbacks ACS inks $130m IT contract with Allergan Laboratory Corp to buy drug discovery services firm Wyeth warns of job cut woes

Related Industry News   SOS: save our solvent! Teva jumps on biologics bandwagon with $400m buy Acquisitions pay off for Novozymes ingredients in 2007 Ventana gives in to Roche merger following increased offer

Breaking News on Outsourcing Pharma
Daily  Tuesday 29 January 2008		Forward to a colleague

	Company Profile Introducing Catalent Pharma Solutions Catalent Pharma Solutions is the leading provider of advanced technologies as well as development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer health companies in nearly 100 countries... Click Here Access Full Stories Pfizer reveals latest Exubera casualties 660 Pfizer employees are the latest casualties of the drug giant's failed bid to capture the diabetes market with its once-touted blockbuster, Exubera... Read Contract downturns cause Catalent cutbacks Unexpected contract downturns have resulted in Catalent Pharma Solutions having to lay off 100 workers at its soft gelatin capsules facility in St Petersburg, Florida... Read ACS inks $130m IT contract with Allergan Affiliated Computer Services (ACS) is on the receiving end of Allergan's decision to outsource its IT functions, inking a $130m contract with the specialty pharma firm... Read Laboratory Corp to buy drug discovery services firm Laboratory Corp has announced its intention to buy fellow US lab services firm Tandem Labs for an undisclosed sum... Read Wyeth warns of job cut woes Wyeth is the latest big pharma firm to warn that major job cuts are on the cards, amidst a series of drug approval setbacks and generic erosion on profits... Read
	All News Headlines for: January | December | November
	Sponsored Link DPT - The Industry Source for Semi-solids and Liquids. DPT is a contract development and manufacturing organization (CDMO) specializing in semi-solid and liquid dosage forms providing solutions from concept to commercialization. Click here to learn more about our services... Click Here
	Related Industry News SOS: save our solvent! In any laboratory, or indeed in any pharmaceutical manufacturing facility, one of the major expenses will be solvents. And just like the price of petrol and diesel it just keeps going up and up. Huw Kidwell examines... Read Teva jumps on biologics bandwagon with $400m buy Israeli generics behemoth Teva is following the market and banking on the promise of biologics with its purchase of Human Genome Sciences biotech spin-off, CoGenesys... Read Acquisitions pay off for Novozymes ingredients in 2007 The small but fast-growing biopharmaceutical ingredients (BPI) business of Denmark's Novozymes, the leading manufacturer of industrial enzymes worldwide, delivered a strong performance in 2007, with sales rising... Read Ventana gives in to Roche merger following increased offer After seven months of offers, refusals and heated exchanges, it seems an increased offer from Roche has finally persuaded the powers that be at Ventana to sell up... Read Weekly comment UK Government plans will stifle innovation, say biotechs New UK Government proposals to scrap Capital Gains Tax (CGT) relief will stifle life science innovation, according to a group of biotech small and medium enterprises (SMEs). Read Previous Headlines Pfizer inks $25m research pact Pfizer has inked an "innovative" research pact with St Louis-based Washington University to the tune of $25m... Read Singapore's biomedical manufacturing down a third in December Another sharp decline in biomedical production saw overall manufacturing output in Singapore fall for the second month running in December, prompting fears that the heavily trade-reliant economy could buckle under... Read AstraZeneca forms cancer collaboration AstraZeneca has announced a new collaboration with the University of Texas' MD Anderson Cancer Center as it steps up its reliance on external partners... Read MDS Pharma opens large Phase I unit MDS Pharma Services has opened its new Phase I clinic in Arizona - the largest of its kind on the US west coast... Read UAE's first pharma 3PL provider springs up A new enterprise in the United Arab Emirates (UAE) is establishing itself as the region's first pharmaceutical-focused third party logistics (3PL) provider... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Product Information - brochures, Web centers Introducing Catalent Pharma Solutions - Company Profile Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com